India Just Did What Millions of Americans Wish the U.S. Government Would Do
India's National Pharmaceutical Pricing Authority levies a game-changing decision this past week meant to improve access to branded medications. Find out how this action could both help and hurt India's citizens, and why it would be nearly impossible to implement in the United States.
‘Reddy’ to Consider This Generic Stock?
Dr. Reddy's is an Indian generic drug maker that is well poised for global and local growth in an environment where innovation is faltering and patent protection expiration are negatively affecting big pharma companies.